| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +1.14M | 100% | $0.77 | +$876K |
| Sells | 0 | ||||
| Net | +3 | +1.14M | 100% | +$876K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Baker Bros. Advisors Lp | Director, 10%+ Owner | $56.6M | Jun 14, 2024 | ||
| Orbimed Advisors Llc | Director, 10%+ Owner | $38.2M | May 22, 2023 | ||
| Krishna Vaddi | CEO, Director | $1.87M | +$699K | +59.9% | Mar 25, 2025 |
| Jane Huang | President, CMO | $388K | Apr 4, 2025 | ||
| Andrew Combs | Chief Chemistry Officer | $332K | +$155K | +87.1% | Mar 25, 2025 |
| Laurent Chardonnet | Chief Financial Officer | $159K | Mar 1, 2024 | ||
| Bryant D. Lim | CLO, CFO, Corp Sec. | $24.8K | +$22.6K | +1042% | Feb 4, 2025 |
| Christopher Pierce | EVP and Chief of Business Oper | $14.1K | Sep 2, 2021 | ||
| Deborah Morosini | EVP, Chief of Clinical Affairs | $1.67K | Feb 15, 2022 | ||
| Martin Babler | Director | Jun 14, 2024 | |||
| Peggy Scherle | Chief Scientific Officer | Feb 4, 2025 | |||
| Mardi Dier | Director | Jun 14, 2024 | |||
| Brian Piper | Chief Financial Officer | Aug 25, 2021 | |||
| David J. Mauro | Chief Medical Officer | Oct 5, 2021 | |||
| Paul A. Friedman | Director | Jun 14, 2024 | |||
| David P. Bonita | Director, 10%+ Owner | Jun 14, 2024 | |||
| Victor Sandor | Director | Jun 14, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|